Literature DB >> 15805906

Results of a multicenter clinical trial to evaluate the preferential hyperacuity perimeter for detection of age-related macular degeneration.

Michaela Goldstein1, Anat Loewenstein, Adiel Barak, Ayala Pollack, Amir Bukelman, Haia Katz, Amira Springer, Andrew P Schachat, Neil M Bressler, Susan B Bressler, Michael J Cooney, Yair Alster, Omer Rafaeli, Rafael Malach.   

Abstract

PURPOSE: To compare the preferential hyperacuity perimeter (PHP) with an Amsler grid in detection of age-related macular degeneration (AMD).
METHODS: Patients underwent refraction, visual acuity examination, PHP, Amsler grid examination, and macular photography.
RESULTS: One hundred fifty patients participated in the trial. Of 19 eyes with neovascular AMD, 19 (100%) were positive on the PHP, and 10 (53%), on the Amsler grid. Of 27 eyes with geographic atrophy, 26 (96%) were positive on the PHP, and 12 (44%), on the Amsler grid. Of 20 eyes with intermediate AMD, 14 (70%) were positive on the PHP, and 4 (20%), on the Amsler grid. Of 51 eyes with early AMD, 21 (41%) were positive on the PHP, and 4 (8%), on the Amsler grid. Of 33 eyes with no AMD, 6 (18%) were positive on the PHP, and none, on the Amsler grid. Thus, 80 (68%) of 117 patients with AMD had a positive PHP, while 30 (26%) had positive results of Amsler grid examination (P < 0.001, McNemar test).
CONCLUSION: The PHP had greater sensitivity, although with a relatively high rate of false-positive results for healthy individuals, than the Amsler grid in detecting AMD-related lesions.

Entities:  

Mesh:

Year:  2005        PMID: 15805906     DOI: 10.1097/00006982-200504000-00008

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  18 in total

1.  [Diagnostics of metamorphopsia in retinal diseases of different origins].

Authors:  C Klatt; P Sendtner; L Ponomareva; J Hillenkamp; A Bunse; V-P Gabel; J Roider
Journal:  Ophthalmologe       Date:  2006-11       Impact factor: 1.059

Review 2.  The Amsler chart: absence of evidence is not evidence of absence.

Authors:  Michael Crossland; Gary Rubin
Journal:  Br J Ophthalmol       Date:  2007-03       Impact factor: 4.638

3.  Role of ganglion cell complex in visual recovery following surgical internal limiting membrane peeling.

Authors:  Luisa Pierro; Lorenzo Iuliano; Marco Gagliardi; Marco Codenotti; Alessandro Ambrosi; Francesco Bandello
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-05-23       Impact factor: 3.117

Review 4.  Diagnostic accuracy of the Amsler grid and the preferential hyperacuity perimetry in the screening of patients with age-related macular degeneration: systematic review and meta-analysis.

Authors:  L Faes; N S Bodmer; L M Bachmann; M A Thiel; M K Schmid
Journal:  Eye (Lond)       Date:  2014-05-02       Impact factor: 3.775

5.  Novel quantitative assessment of metamorphopsia in maculopathy.

Authors:  Emily Wiecek; Kameran Lashkari; Steven C Dakin; Peter Bex
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-11-18       Impact factor: 4.799

6.  Assessment of visual distortions in age-related macular degeneration: emergence of new approaches.

Authors:  Noelia Pitrelli Vazquez; Paul C Knox
Journal:  Br Ir Orthopt J       Date:  2015

7.  Quantification of visual field loss in age-related macular degeneration.

Authors:  Jennifer H Acton; Jonathan M Gibson; Robert P Cubbidge
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

8.  Morphision: a method for subjective evaluation of metamorphopsia in patients with unilateral macular pathology (i.e., full thickness macular hole and epiretinal membrane).

Authors:  Marta Ugarte; Manoharan Shunmugam; D Alistair H Laidlaw; Tom H Williamson
Journal:  Indian J Ophthalmol       Date:  2013-11       Impact factor: 1.848

Review 9.  Strategies for improving early detection and diagnosis of neovascular age-related macular degeneration.

Authors:  Pearse A Keane; Gabriella de Salvo; Dawn A Sim; Srini Goverdhan; Rupesh Agrawal; Adnan Tufail
Journal:  Clin Ophthalmol       Date:  2015-02-17

10.  M-charts as a tool for quantifying metamorphopsia in age-related macular degeneration treated with the bevacizumab injections.

Authors:  Katarzyna Nowomiejska; Agnieszka Oleszczuk; Agnieszka Brzozowska; Andrzej Grzybowski; Katarzyna Ksiazek; Ryszard Maciejewski; Piotr Ksiazek; Anselm Juenemann; Robert Rejdak
Journal:  BMC Ophthalmol       Date:  2013-04-15       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.